Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.ufc.br/handle/riufc/28503
Tipo: | Artigo de Periódico |
Título : | Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management |
Autor : | Aragão, Ricardo Evangelista Marrocos de Barreira, Ieda Maria Alexandre Muccioli, Cristina Oliveira Neto, Francisco Holanda Arrais, Barbara Lorena Alves Oliveira, Francisco George Magalhães de Carneiro, Gustavo Jose Arruda Mendes |
Palabras clave : | Vasculite Retiniana;Retinal Vasculitis |
Fecha de publicación : | sep-2017 |
Editorial : | Revista de Medicina da UFC |
Citación : | ARAGÃO, R. E. M.de et al. Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management. Rev Med UFC, Fortaleza, v. 57, n. 3, p. 54-57, set./dez. 2017. |
Abstract: | Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents. |
URI : | http://www.repositorio.ufc.br/handle/riufc/28503 |
ISSN : | 0100-1302 (Impresso) 2447-6595 (Eletrônico) |
Aparece en las colecciones: | DMC - Artigos publicados em revistas científicas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
2017_art_remaragão.pdf | 1,25 MB | Adobe PDF | Visualizar/Abrir |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.